Allison Kwong is a hepatologist who specializes in the care of patients with chronic liver disease. Her research in alcohol-associated liver disease has been supported by the AASLD Foundation Clinical, Translational, and Outcomes Research Award and a NIAAA K23 Mentored Career Development Award. Her clinical and research interests include cirrhosis, portal hypertension, and outcomes before and after liver transplantation.

I studied Medicine at the Catholic University of Louvain in Belgium. A fter graduating in 1982, I completed an Internal Medicine Residency in New York City. Thereafter, I entered the Gastroenterology and Hepatology Fellowship at the University of Southern California (USC), graduating in 1989. My professional career started at the University of Missouri-Kansas City, followed by a return at USC from 1992-2001 and a Liver Transplant position at California Pacific Medical Center from 2002-2012.

I am a physician-scientist and hepatologist at the University of Southern California with a research interest in Drug-Induced Liver Injury and Autoimmune Liver Diseases. I study mechanisms of liver injury and hepatotoxicity with a particular focus on cell death pathways using basic, animal model, and translational approaches. My lab currently focuses on Immune-mediated Liver Injury from Checkpoint Inhibitors and the complex interplay if signaling mechanisms leading to hepatotoxicity in immunotherapy.

Dr. Jones, a Hepatologist and Associate Professor of Clinical Medicine, trained at the University of North Carolina for Gastroenterology and Transplant Hepatology. She joined University of Miami faculty in 2015. She takes a multi-pronged approach to researching disparities in hepatocellular carcinoma (HCC) and chronic liver disease. She used community-based participatory research to test the feasibility and acceptability of home-based hepatitis B screening. Dr.

Hepatologist, Professor of Medicine and Head of the Division of Hepatology, Liver and Liver Transplant Clinic at Groote Schuur Hospital and the Univeristy of Cape Town, Cape Town, South Africa.

Associate Professor<br>Division of Gastroenterology and Hepatology<br>Department of Internal Medicine<br>Kangbuk Samsung Hospital<br>Sungkyunkwan University School of Medicine

Dr. Patricia Bloom is an Assistant Professor and transplant hepatologist at the Mayo Clinic. She performs clinical and translational research to improve outcomes in decompensated cirrhosis, especially for hepatic encephalopathy. Her goals are to create and test innovative microbiome therapies to treat hepatic encephalopathy and other cirrhosis complications. She is also developing innovative technology solutions for the management of decompensated cirrhosis. She serves as an Associate Editor for Hepatology Communications and on the Mentorship and Membership Committee of AASLD.

Dr. Young Chang, MD, PhD, is an Assistant Professor of Medicine at Soonchunhyang University Seoul Hospital, Korea. She trained in Internal Medicine and Hepatology at Seoul National University Hospital, with research interests in metabolic liver disease, viral hepatitis, cirrhosis, and hepatocellular carcinoma. She is an active member of the Korean Association for the Study of the Liver and the Korean Liver Cancer Association, serving on multiple academic committees.

Dr. Dhanasekaran is a physician scientist specializing in liver cancer research and patient care. Dr. Dhanasekaran completed her medical school training in India, and pursued her Internal Medicine residency at the University of Florida, Gainesville followed by Gastroenterology fellowship at Mayo Clinic, Rochester and Transplant Hepatology fellowship and PhD in Cancer Biology at Stanford University. Her clinical practice is mainly focused on liver cancer and she runs a clinic specifically for patients with liver masses. At Stanford, Dr.